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Drug resistant Acinetobacter baumannii topped the list for antibiotic resistant 
‘critical’ pathogens that was released by the World Health Organisation (WHO) in 
February 2017. The list was intended to guide and promote research and development 
(R&D) of antibiotics. One of the factors that may contribute to A. baumannii virulence 
are the secretory proteases that this bacteria produces. In order to design effective 
antibiotocs and treatment targeting secretory proteases from A. baumannii, the gene 
coding for the proteases needed to be cloned to produce recombinant form of the 
proteins that can be easily expressed and purified in the quantities and purity suitable 
for functional and structural studies. A secreted serine protease was identified from A. 
baumannii, termed as “SPSFQ”. Bioinformatics analysis using BLAST and multiple 
sequence alignment indicated that the enzyme belonged to serine endopeptidases (E.C. 
3.4.21.-) family with a predicted catalytic triad motif of D130/H163/S315. Structure 
of SPSFQ modelled using the homology modeling software, I-TASSER revealed that 
the enzyme folding  was highly conserved to keratinase 5WSL with seven stranded 
parallel β sheets flanking by six α helices and four β sheets made of two anti-parallel 
strands. SPSFQ with 1104 bp coding for 368 amino acids was subcloned into pET-
22b(+) between BamH1 and Sal1 and expressed in periplasmic fraction of E. coli BL21 
(DE3). Total cell protein with induction condition at 16 ºC and 25 ºC with 1mM IPTG 
showed two distinct bands around 40 kDa (proenzyme form) and 30 kDa (active form) 
in western blot. Cell lysate did not show any activity during enzymatic assay probably 
because of SPSFQ was expressed in inclusion form. As a conclusion, SPSFQ was 
successfully sub-cloned and expressed in E. coli BL21 (DE3). Further study will focus 
on purification and characterization of SPSFQ in order to identify the cellular 






Perintang antibiotik Acinetobacter baumannii telah disenaraikan sebagai 
pathogen yang utama oleh World Health Organization (WHO) pada Februari 2017. 
Senarai tersebut telah disediakan sebagai panduan untuk penyelidikan dan 
pembangunan (R&D) antibiotik. Salah satu faktor yang menyumbang kepada kebisaan 
A. baumannii adalah rembesan proteasenya ke luar sel. Rekaan antibiotik dan rawatan 
yang berkesan berasaskan protease yang dikeluarkan oleh A. baumannii memerlukan 
gen tersebut diklon, diekspres dan ditulenkan untuk pengajian. Satu protease 
dinamakan “SPSFQ” telah dipencil dari A. baumannii. BLAST dan perbandingan 
urutan menunjukkan SPSFQ merupakan “serine endopeptidase” (E.C. 3.4.21.-) 
dengan asid amino yang aktif pada D130/H163/S315. Struktur protease telah dirangka 
dengan I-TASSER dan menunjukkan protease mempunyai struktur yang serupa 
dengan 5WSL (keratinase), iaitu tujuh strand “β sheets” selari diapit dengan enam “α 
helices” dan empat “β sheets” yang dibentuk dengan dua anti-selari strand. SPSFQ 
yang mengandungi 1104 pasangan bes dan membentuk 368 asid amino telah diklon ke 
dalam pET-22b(+), antara tapak sekatan BamHI dan SalI dan diekspres dalam ruang 
periplasmik E. coli BL21 (DE3). Jumlah protein sel dengan induksi pada 16 ºC dengan 
dan 25 ºC dengan 1mM IPTG telah menunjukkan protease ada pada  sekitar 40 kDa 
(enzim yang tidak matang) dan 30 kDa (enzim yang matang) pada SDS-PAGE. Sel 
yang telah dimusnahkan tidak menunjukkan sebarang aktiviti mungkin disebabkan 
SPSFQ tidak larut air. Secara kesimpulan, SPSFQ telah berjaya diklon dan diekspres 
oleh E. coli BL21 (DE3). Kajian seterusnya akan memberi tumpuan kepada 
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1.1 Background of Study 
On 27th February 2017, World Health Organization had announced “Global 
priority list of antibiotic-resistant bacteria to guide research, discovery, and 
development of new antibiotics” and carbapenem resistant Acinetobacter baumanii 
was categorized in the critical level together with carbapenem resistant Pseudomonas 
aeruginosa and Enterobacteriaceae (World Health Organization, 2017).  
Acinetobacter baumannii, a Gram-negative cocci is ubiquitous and can be 
found across wide geographical areas. In the last decade or so, A. baumannii has 
emerged to be one of the main sources of opportunistic nosocomial infections in 
healthcare facilities where instrument contaminated with the bacteria that was later 
used for intubation or other similar application. Infection of such bacteria may cause 
several types of diseases including pneumonia, sepsis, bacteremia, soft tissue infection 
and meningitis (Wang et al., 2014). Cases of A. baumannii showed a two-fold increase 
in occurrences in Malaysia from the year 2006 to 2007 (Ministry of Health Malaysia, 
2008). Studies had shown that the period of time where patient stays in ICU is 
proportional to the rate of infection by such multi drug resistant (MDR) bacteria. 
Where those who underwent surgery are 2.2 times more likely to acquire such infection 






1.2 Problem Statement  
 Currently, A. baumannii had been identified to be resistant towards 
disinfectants, able to form robust biofilms, better desiccation tolerance and together 
with MDR had helped the bacteria to survive in different harsh environment (Kamolvit 
et al., 2015). The hardier bacteria has rendered common and current treatment options 
of infections less effective, and will soon be pandrug resistant as available antibiotics 
are no longer able to control the bacteria. Characterization of the bacteria and its 
virulence properties are being prioritized by most of the researchers in order to reveal 
its weakness to speed up new drug designs (Mendez et al., 2012).  
 
 Extracellular proteome of A. baumannii have to be analyzed to provide insight 
to the infection mechanism. Among the important enzymes that contribute to A. 
baumannii survival, extracellular proteases seems to play a vital role although only 
two extracellular protease (CpaA and PKF) were characterized (Tilley et al., 2014; 
King et al., 2013). The disruption of both CpaA and PKF expression shows significant 
effect to the A. baumannii survival and pathogenicity. Hence, further knowledge on 
the extracellular proteome of A. baumannii is of great importance for the design of 
next generation antibiotic. Hereby, one of the serine protease gene was isolated from 
A. baumannii and cloned into expression host for characterization, identifying its role 
for cellular importance and infections. 
1.3 Objectives 
The objectives of this study include: 
 
i. To analyze SPSFQ using bioinformatics tools. 
ii. To subclone SPSFQ from pGEM into pET-22b(+). 
iii. To carry out preliminary expression of recombinant protein in E. coli BL21 





1.4 Scope of Study 
The scopes of the study are as below:  
 
i. Bioinformatics analysis of SPSFQ. 
ii. Subcloning of serine protease gene SPSFQ from pGEM into pET-22b(+). 
iii. Transformation of E. coli BL21 (DE3) with SPSFQ/pET-22b(+). 
iv. Culture of the recombinant E. coli BL21 (DE3) in LB medium with 
carbenicillin. 
v. Sequencing of the recombinant gene cloned into E. coli BL21 (DE3). 
vi. Preliminary expression of the recombinant E. coli BL21 (DE3) with IPTG. 
vii. Lysis of the recombinant E. coli BL21 (DE3) to extract crude enzyme of 
SPSFQ.  
viii. Screening for enzymatic reaction with plate method. 
ix. Using SDS-PAGE to detect the expression of SPSFQ. 
x. Using Western blot to verify the expression of SPSFQ. 
1.5 Significance of Study 
 Protease PKF isolated from A. baumannii showed inhibition to biofilm 
formation and enhanced bacterial growth in human serum (King et al., 2013). 
Extracellular protease CpaA deregulates blood coagulation was also isolated from 
clinical strain (Tilley et al., 2014). These research had demonstrated the importance of 
extracellular proteases in growth and propagation of A. baumannii in human host. 
Besides, strains of A. baumannii had been reported to gain resistant towards the 
antibiotic of last resort known as polymyxin  (Lean et al., 2014). Hence, understanding 
of the isolated protease SPSFQ may provide information on whether it can be used as 
new target for future drug design, providing more treatment options when he bacteria 
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